NO20004053L - Glukokortikoid-selektive antiinflammatoriske midler - Google Patents

Glukokortikoid-selektive antiinflammatoriske midler

Info

Publication number
NO20004053L
NO20004053L NO20004053A NO20004053A NO20004053L NO 20004053 L NO20004053 L NO 20004053L NO 20004053 A NO20004053 A NO 20004053A NO 20004053 A NO20004053 A NO 20004053A NO 20004053 L NO20004053 L NO 20004053L
Authority
NO
Norway
Prior art keywords
glucocorticoid
inflammatory agents
selective anti
mammal
compounds
Prior art date
Application number
NO20004053A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004053D0 (no
Inventor
Michael J Coughlan
Steven W Elmore
Michael E Kort
Philip R Kym
Jimmie L Moore
John K Pratt
Alan X Wang
James P Edwards
Todd Kevin Jones
Original Assignee
Abbott Lab
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab, Ligand Pharm Inc filed Critical Abbott Lab
Publication of NO20004053D0 publication Critical patent/NO20004053D0/no
Publication of NO20004053L publication Critical patent/NO20004053L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20004053A 1998-02-13 2000-08-11 Glukokortikoid-selektive antiinflammatoriske midler NO20004053L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2394798A 1998-02-13 1998-02-13
US24783199A 1999-02-10 1999-02-10
PCT/US1999/003127 WO1999041256A1 (en) 1998-02-13 1999-02-12 Glucocorticoid-selective anti-inflammatory agents

Publications (2)

Publication Number Publication Date
NO20004053D0 NO20004053D0 (no) 2000-08-11
NO20004053L true NO20004053L (no) 2000-09-11

Family

ID=26697833

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004053A NO20004053L (no) 1998-02-13 2000-08-11 Glukokortikoid-selektive antiinflammatoriske midler

Country Status (20)

Country Link
EP (1) EP1053239B1 (de)
JP (1) JP2002503665A (de)
KR (1) KR20010040935A (de)
CN (1) CN1119348C (de)
AT (1) ATE230749T1 (de)
AU (1) AU766441B2 (de)
BG (1) BG64317B1 (de)
BR (1) BR9907788A (de)
CA (1) CA2320943A1 (de)
DE (1) DE69904804T2 (de)
DK (1) DK1053239T3 (de)
ES (1) ES2192035T3 (de)
HU (1) HUP0100460A3 (de)
IL (1) IL137508A0 (de)
NO (1) NO20004053L (de)
NZ (1) NZ506013A (de)
PL (1) PL193323B1 (de)
SK (1) SK284689B6 (de)
TR (1) TR200003094T2 (de)
WO (1) WO1999041256A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506766B1 (en) * 1998-02-13 2003-01-14 Abbott Laboratories Glucocortiocoid-selective antinflammatory agents
CO5180649A1 (es) * 1999-09-01 2002-07-30 Abbott Lab Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
US6593480B2 (en) * 1999-09-01 2003-07-15 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6329534B1 (en) 1999-09-01 2001-12-11 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6436986B1 (en) 1999-09-01 2002-08-20 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
ES2246292T3 (es) 2000-10-30 2006-02-16 Pfizer Products Inc. Moduladores de receptor glucocorticoide.
WO2003002548A1 (en) * 2001-06-29 2003-01-09 Abbott Laboratories A process for the preparation of chiral glucocorticoid receptor agents
US6608216B2 (en) 2001-06-29 2003-08-19 Abbott Laboratories Process for the preparation of chiral glucocorticoid receptor agents
US6518430B1 (en) * 2001-09-21 2003-02-11 Abbott Laboratories Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
EP1467982B8 (de) 2002-01-14 2007-04-11 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon
EP1490317A1 (de) 2002-03-26 2004-12-29 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid-mimetika, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen, und ihre verwendungen
JP4324480B2 (ja) 2002-03-26 2009-09-02 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメティクス、その製法、医薬組成物、及び使用
WO2003086294A2 (en) 2002-04-11 2003-10-23 Merck & Co., Inc. 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
CA2496175A1 (en) 2002-08-21 2004-03-04 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
TW200410968A (en) 2002-10-11 2004-07-01 Ligand Pharm Inc 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
DE20301728U1 (de) * 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
AR040783A1 (es) * 2002-10-11 2005-04-20 Ligand Pharm Inc 5-(1',1'-cicloaquil/alquenil) metiliden-1,2 -dihidro-5-h-cromeno [3,4- f] quiinolinas como compuestos moduladores selectivos de receptores de progesterona
EP1583745A1 (de) 2003-01-03 2005-10-12 Boehringer Ingelheim Pharmaceuticals Inc. 1-propanol- und 1-propylaminderivate undderen verwendung als glucocorticoidliganden
US20070088042A1 (en) 2004-09-09 2007-04-19 Meissner Robert S Fluorinated 4-azasteroid derivatives as androgen receptor modulators
US7235662B2 (en) 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
JP4468369B2 (ja) 2003-10-16 2010-05-26 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド ある種のトリフルオロメチル置換アルコールの立体選択的合成
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
PE20060776A1 (es) 2004-12-27 2006-09-26 Boehringer Ingelheim Pharma Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
US8017775B2 (en) * 2005-09-14 2011-09-13 Santen Pharmaceutical Co., Ltd. 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
TW201111392A (en) 2009-06-16 2011-04-01 Schering Corp Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof
US20120220590A1 (en) 2009-07-31 2012-08-30 Thombare Pravin S Novel compounds as modulators of glucocorticoid receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU717251B2 (en) * 1994-12-22 2000-03-23 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods

Also Published As

Publication number Publication date
TR200003094T2 (tr) 2001-01-22
ATE230749T1 (de) 2003-01-15
PL193323B1 (pl) 2007-02-28
EP1053239A1 (de) 2000-11-22
CN1119348C (zh) 2003-08-27
DE69904804D1 (de) 2003-02-13
CA2320943A1 (en) 1999-09-19
DK1053239T3 (da) 2003-04-22
AU2677399A (en) 1999-08-30
SK11972000A3 (sk) 2001-08-06
KR20010040935A (ko) 2001-05-15
CN1296486A (zh) 2001-05-23
BG64317B1 (bg) 2004-09-30
ES2192035T3 (es) 2003-09-16
PL343018A1 (en) 2001-07-30
EP1053239B1 (de) 2003-01-08
DE69904804T2 (de) 2003-11-06
HK1033308A1 (en) 2001-08-24
NO20004053D0 (no) 2000-08-11
WO1999041256A1 (en) 1999-08-19
IL137508A0 (en) 2001-07-24
BR9907788A (pt) 2001-10-30
SK284689B6 (sk) 2005-09-08
AU766441B2 (en) 2003-10-16
BG104719A (en) 2001-05-31
HUP0100460A2 (hu) 2001-09-28
HUP0100460A3 (en) 2003-03-28
NZ506013A (en) 2003-03-28
JP2002503665A (ja) 2002-02-05

Similar Documents

Publication Publication Date Title
DK1053239T3 (da) Gluccocorticoid-selektive, anti-inflammatoriske midler
DK1053240T3 (da) Glucocorticoid-selektiv antiinflammatoriske midler
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
BG105109A (en) Cell adhesion-inhibiting anti-inflammatory compounds
EP1034164A4 (de) Beta-alanin-derivate als zell-adhäsions-inhibitoren
FI973087A7 (fi) Soluadheesion inhibiittoreita
BG105880A (en) Compounds useful as anti-inflammatory agents
BR9811099A (pt) Inibidores de urocinase
DE69925508D1 (de) Zelladhäsion- und entzündungshemmende immunosuppressive verbindungen
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
MY128261A (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
WO2000006137A3 (en) Glucocorticoid-selective anti-inflammatory agents
BG100248A (bg) Инхибитори на скваленсинтетаза
IT1274022B (it) Derivati della cumarina ad attivita' farmacologica, loro uso e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application